A new injectable contraceptive platform developed with Gates Foundation funding is being promoted as a “nonsurgical option for women,” but its self-assembling drug delivery mechanism and potential for future adaptation to neuropsychiatric and infectious disease drugs raise serious safety, ethical, and biosecurity concerns.
Click Here for More Information